Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 19, 2026 | CMS / Medicare | White Cell Colony Stimulating Factors | Metadata changed |
| May 19, 2026 | CMS / Medicare | Coenzyme Q10 (CoQ10) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Transcranial Magnetic Stimulation (TMS) | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: DecisionDx-UM (Uveal Melanoma) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Lab: Coenzyme Q10 (CoQ10) | Metadata changed |
| May 19, 2026 | CMS / Medicare | BDX-XL2 | Metadata changed |
| May 19, 2026 | CMS / Medicare | BDX-XL2 | Metadata changed |
| May 19, 2026 | CMS / Medicare | Lab: Coenzyme Q10 (CoQ10) | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Oncotype DX Breast Cancer for DCIS (Genomic Health) | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Oncotype DX Breast Cancer for DCIS (Genomic Health) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Polysomnography and Other Sleep Studies | Metadata changed |
| May 19, 2026 | CMS / Medicare | GlycoMark Testing for Glycemic Control | Metadata changed |
| May 19, 2026 | CMS / Medicare | Polysomnography and Other Sleep Studies | Metadata changed |
| May 19, 2026 | CMS / Medicare | Systematic Review of ECG-based Signal Analysis Technologies for Evaluating Patients With Acute Coronary Syndrome | Metadata changed |
| May 19, 2026 | CMS / Medicare | Lifestyle Interventions for Four Conditions: Type 2 Diabetes, Metabolic Syndrome, Breast Cancer, and Prostate Cancer | Metadata changed |
| May 19, 2026 | CMS / Medicare | Aortography and peripheral angiography | Metadata changed |
| May 19, 2026 | CMS / Medicare | GlycoMark Testing for Glycemic Control | Metadata changed |
| May 19, 2026 | CMS / Medicare | Serum Magnesium | Metadata changed |
| May 19, 2026 | CMS / Medicare | Vitamin D Assay Testing | Metadata changed |
| May 19, 2026 | CMS / Medicare | Lab: Bladder/Urothelial Tumor Markers | Metadata changed |
| May 19, 2026 | CMS / Medicare | ProMark Risk Score | Metadata changed |
| May 19, 2026 | CMS / Medicare | Polysomnography | Metadata changed |
| May 19, 2026 | CMS / Medicare | Total Knee Arthroplasty | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: HLA-DQB1*06:02 Testing for Narcolepsy | Metadata changed |
| May 19, 2026 | CMS / Medicare | Treatment of Males with Low Testosterone | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: HLA-DQB1*06:02 Testing for Narcolepsy | Metadata changed |
| May 19, 2026 | CMS / Medicare | Transcranial Magnetic Stimulation (TMS) | Metadata changed |
| May 19, 2026 | CMS / Medicare | The Impact of Pre-Transplant Red Blood Cell Transfusions in Renal Allograft Rejection | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Breast Cancer Assay: Prosigna | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Breast Cancer Assay: Prosigna | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Biomarkers in Cardiovascular Risk Assessment | Metadata changed |
| May 19, 2026 | CMS / Medicare | Lab: Special Histochemical Stains and Immunohistochemical Stains | Metadata changed |
| May 19, 2026 | CMS / Medicare | Lab: Special Histochemical Stains and Immunohistochemical Stains | Metadata changed |
| May 19, 2026 | CMS / Medicare | Diagnostic Abdominal Aortography and Renal Angiography | Metadata changed |
| May 19, 2026 | CMS / Medicare | Bowel Management Devices | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: NRAS Genetic Testing | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Biomarkers in Cardiovascular Risk Assessment | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Biomarkers in Cardiovascular Risk Assessment | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Breast Cancer Assay: Prosigna | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: MGMT Promoter Methylation Analysis | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Genetic Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Urine Drug Testing | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Molecular Diagnostic Tests (MDT) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Special Histochemical Stains and Immunohistochemical Stains | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: MGMT Promoter Methylation Analysis | Metadata changed |
| May 19, 2026 | CMS / Medicare | Lab: Special Histochemical Stains and Immunohistochemical Stains | Metadata changed |
| May 19, 2026 | CMS / Medicare | Somatosensory Testing | Metadata changed |
| May 19, 2026 | CMS / Medicare | Nerve Conduction Studies and Electromyography | Metadata changed |